Table 1. Clinic-pathologic characteristics of patients.

		Patients (n = 72)
Sex	Female Male	37 (51.4%) 35 (48.6%)
Age (years)	Median (range) ≤ 52 > 52	52 (23–80) 39 (54.2%) 33 (45.8%)
Primary melanoma site	Head Limb Trunk Unknown	10 (13.9%) 40 (55.6%) 17 (23.6%) 5 (6.9%)
Metastases timing	Synchronous Metachronous	9 (12.5%) 63 (87.5%)
M-stage at study entry (TNM VII. ed)	1a 1b 1c	25 (34.7%) 6 (8.3%) 41 (56.9%)
Number of metastases	≤ 2 > 2	18 (25%) 54 (75%)
Serum LDH	Normal High NA	27 (37.5%) 21 (29.2%) 24 (33.3%)
Neutrophiles/Lymphocites ratio	≤ 5 > 5 NA	45 (62.5%) 7 (9.7%) 20 (27.8%)
Combined medical therapy	No Yes	17 (23.6%) 55 (76.4%)
Surgical resection	No Yes	57 (79.2%) 15 (20.8%)
Radiotherapy	No Yes	57 (79.2%) 15 (20.8%)

NA, not available data.